LGALS4 and breast carcinoma: The free circulating level of galectin-4 in serum was significantly higher in patients with colon, hepatocellular, and breast cancer, in particular, those with metastasis (Barrow et al., 2011; Barrow et al., 2013; Kim et al., 2013; Cai et al., 2014).